DGX
Quest Diagnostics Incorporated
NYSE · Healthcare · Medical - Diagnostics & Research · US
$237.58
−0.76%Margins
Gross margin
33.1%
EBITDA margin
17.4%
EBIT margin
14.1%
Net margin
9.2%
FCF margin
10.6%
14.1%
Return on equity
6.3%
Return on assets
11.8%
Return on invested capital
0.69x
Asset turnover
$1.8B
Cash from operations
$5.67
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026